TSO3 to resubmit for U.S. clearance

TSO3 (TSX:TOS) has received instructions from U.S. regulatory authorities to resubmit a 510k for its Sterizone 125L + Sterilizer with “additional data” and to “better establish the link between the sterilizer and a variety of accessory products used in the sterilizer,” which are also subject to 510k clearance and have been previously submitted. “TSO3 is [...]

TSO3 gets boost from FDA decision

The FDA has advised U.S. health care administrators to discontinue use of Steris Corp.’s (NYSE:STE) peracetic acid-based endoscope reprocessing device System 1 within 18 months. In a research report, Versant Partners says the FDA decision is positive for TSO3 (TSX:TOS) because a competitor will exit the market by mid-2011.  Analyst Doug Loe writes that TSO3’s [...]